Baricitinib for relapsing giant cell arteritis: a prospective open-label 52-week pilot study
Matthew J. Koster, Cynthia S. Crowson, Rachel Giblon, Jane Jaquith, Alí Duarte‐García, Eric L. Matteson, Cornelia M. Weyand, Kenneth J. Warrington
Topics & Concepts
MedicineDiscontinuationAdverse effectNauseaGiant cell arteritisPrednisoneInternal medicineProspective cohort studySurgeryGastroenterologyVasculitisDiseaseVasculitis and related conditionsOtitis Media and Relapsing PolychondritisWhipple's Disease and Interleukins